GWM
TNDM icon

Gilpin Wealth Management’s Tandem Diabetes Care TNDM Stock Holding History

Gilpin Wealth Management’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$98 Sell
6
-3
-33% -$56 ﹤0.01% 1303
2026
Q2 		$136 Sell
9
-3
-25% -$52 ﹤0.01% 993
2026
Q1 		$231 Buy
12
+7
+140% +$152 ﹤0.01% 828
2025
Q4 		$110 Buy
+5
New +$90 ﹤0.01% 812

Other funds holding TNDM

GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
TFA
Toth Financial Advisory Leesburg, Virginia $1B AUM 19.18% 1-Year Est. Return
EB
Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return
DCM
Davis Capital Management Jacksonville, Florida $167M AUM 17.17% 1-Year Est. Return

Gilpin Wealth Management's TNDM Position: Q3 2026 in Review

Gilpin Wealth Management reduced its Tandem Diabetes Care (TNDM) stake by 33% in Q3 2026, selling an estimated $56 and leaving 6 shares worth $98. The position accounts for ﹤0.01% of the portfolio, ranked #1303.

Gilpin Wealth Management first reported a position in TNDM in Q4 2025 and has held it in 4 quarters since. The position peaked at $231 in Q1 2026. 9 funds tracked by Wall St. Rank hold TNDM as of Q3 2026.

  • Gilpin Wealth Management held 6 shares of Tandem Diabetes Care worth $98 as of Q3 2026.
  • Gilpin Wealth Management sold 3 Tandem Diabetes Care shares in Q3 2026, an estimated $56.
  • Tandem Diabetes Care made up ﹤0.01% of Gilpin Wealth Management's portfolio in Q3 2026, its #1303 holding.
  • Gilpin Wealth Management first reported a position in Tandem Diabetes Care in Q4 2025 and has held it in 4 quarters since.
  • Gilpin Wealth Management's Tandem Diabetes Care position peaked at $231 in Q1 2026.
  • 9 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q3 2026.

Based on Gilpin Wealth Management's 13F filing for Q3 2026, filed 9 Oct 2026.